Clinical Trial Update: Study of Ruxolitinib in Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for ruxolitinib in pancreatic cancer has completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-29